Drug Name:
LEVSIN Rx

Generic Name and Formulations:
Hyoscyamine sulfate 0.125mg; scored tabs.
Company:
Meda Pharmaceuticals
Therapeutic Use:
Indications for LEVSIN:
Adjunct in peptic ulcer. Irritable bowel syndrome. Infant colic.
Adult:
1–2 tabs or 5–10mL every 4 hrs or as needed; max 12 tabs or 60mL daily.
Children:
Infants <10kg: use drops.
Contraindications:
Glaucoma. Unstable cardiovascular status in acute hemorrhage. GI or urinary tract obstruction. Paralytic ileus, intestinal atony of elderly or debilitated patients. Toxic megacolon. Severe ulcerative colitis. Myasthenia gravis.
Warnings/Precautions:
High environmental temperature. Diarrhea. Autonomic neuropathy. Impaired cardiac or renal function. Cardiovascular disease. Hypertension. Hyperthyroidism. Hiatal hernia with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers.
Interactions:
Antacids may inhibit absorption. Additive anticholinergic effects with other anticholinergics, amantadine, type I antiarrhythmics, antihistamines, phenothiazines, tricyclics, MAOIs.
See Also:
Pharmacological Class:
Anticholinergic.
Adverse Reactions:
Anticholinergic effects, drowsiness.
Note:
Formerly known under the brand name Levsin Drops.
How Supplied:
Tabs, SL—100, 500; Drops—contact supplier
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Anemia
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetes
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Hemodialysis
- Hyperphosphatemia
- Hypertension
- Hyperuricemia
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Transplantation